Stille (8R6) Stock Overview

Develops, manufactures, and distributes medtech products in Sweden, Germany, the United Kingdom, Switzerland, North America, the United States, and internationally. More details

8R6 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	4/6
Past Performance	5/6
Financial Health	6/6
Dividends	0/6

Rewards

Trading at 50.7% below our estimate of its fair value

Earnings are forecast to grow 22.33% per year

Earnings grew by 33% over the past year

Risk Analysis

8R6 passed our risk checks.

8R6 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW477,249 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

477,249 investors already sharing narratives

View all narratives

Stille AB Competitors

Price History & Performance

Summary of share price highs, lows and changes for Stille
Historical stock prices
Current Share Price	SEK 20.90
52 Week High	SEK 25.05
52 Week Low	SEK 16.45
Beta	0.38
1 Month Change	-6.90%
3 Month Change	-3.46%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	22.94%

Recent updates

Shareholder Returns

	8R6	DE Medical Equipment	DE Market
7D	-6.1%	8.7%	3.0%
1Y	n/a	-22.1%	1.8%

Return vs Industry: Insufficient data to determine how 8R6 performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how 8R6 performed against the German Market.

Price Volatility

Is 8R6's price volatile compared to industry and market?
8R6 volatility
8R6 Average Weekly Movement	5.2%
Medical Equipment Industry Average Movement	5.7%
Market Average Movement	5.4%
10% most volatile stocks in DE Market	12.8%
10% least volatile stocks in DE Market	2.7%

Stable Share Price: 8R6 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 8R6's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1841	225	Ulrik Berthelsen	www.stille.se

Stille AB develops, manufactures, and distributes medtech products in Sweden, Germany, the United Kingdom, Switzerland, North America, the United States, and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including SuperCut, eye, blepharoplasty, operating, vascular, tenotomy, and face-lift scissors; colon, gall duct, multi-purpose, tangential occlusion, peripheral vascular, and anastomosis clamps; skin and nerve hooks, retractors, rib spreaders, self-retaining and trachea retractors, and nasal specula; and dressing, diathermy, knot-holding, tissue, iris, dura, and vascular forceps under the STILLE, Fehling, S&T, and Surgical Holdings brands.

Stille AB Fundamentals Summary

How do Stille's earnings and revenue compare to its market cap?
8R6 fundamental statistics
Market cap	€186.53m
Earnings (TTM)	€6.61m
Revenue (TTM)	€61.87m

28.2x

P/E Ratio

3.0x

P/S Ratio

Is 8R6 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8R6 income statement (TTM)
Revenue	SEK 679.58m
Cost of Revenue	SEK 344.16m
Gross Profit	SEK 335.42m
Other Expenses	SEK 262.82m
Earnings	SEK 72.59m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

Oct 23, 2026

Earnings per share (EPS)	8.08
Gross Margin	49.36%
Net Profit Margin	10.68%
Debt/Equity Ratio	0%

How did 8R6 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/31 02:49
End of Day Share Price	2026/07/31 00:00
Earnings	2026/06/30
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Stille AB is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Johan Löchen	ABG Sundal Collier Sponsored
Christian Lee	Pareto Securities
Filip Einarsson	Redeye

Stille ABDB:8R6 Stock Report